go back

New Mexico rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $676,083 · 10th–90th $562,341–$1,949,8450%20%40%10th90th$676,083Professionalmedian $562,341 · 10th–90th $562,341–$645,6540%50%90th$562,341$0.1$1.0$20.0$500.0$10.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$616,595.00 / $870,963.59 / $1,949,844.60
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $645,654.23
Molina
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$512,861.38 / $512,861.38 / $1,122,018.45
Providence
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $588,843.66 / $933,254.30
Providence
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$616,595.00 / $645,654.23 / $812,830.52
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$512,861.38 / $562,341.33 / $851,138.04
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$512,861.38 / $512,861.38 / $549,540.87